Anti-Microbial Savior BioteQ Co., Ltd. (6864.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0006864002
Anti-Microbial Savior BioteQ Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 612,000.00 TWD | 706,000.00 TWD |
| Gross profit | 144,000.00 TWD | 326,000.00 TWD |
| Operating income | -76.48 m TWD | -95.99 m TWD |
| EBIT | -74.49 m TWD | -93.58 m TWD |
| Net income | -74.52 m TWD | -93.60 m TWD |
| Diluted EPS – continuing operations | -2.27 TWD | -2.48 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Anti-Microbial Savior BioteQ Co., Ltd.
Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical drug products in Taiwan. The company offers PoroVance precision pore engineering and small-molecule drug discovery. Its pipeline products include FORMOSA-1117, antibacterial drug candidate; YUAN-03, antiviral drug candidate; AMS-2140, broad-spectrum antiviral drug candidate; TenTacle, ADC linker-conjugate compound. Anti-Microbial Savior BioteQ Co., Ltd. was founded in 2018 and is headquartered in Kaohsiung, Taiwan.
More stocks
- CULP INC (CULP)
- Sigong Tech Co. Ltd (020710.KQ)
- Pirate Gold Corp. (YARR.V)
- Han Shin Mach (011700.KS)
- Kumho HT Inc (214330.KS)
- WISEnut, Inc. (096250.KQ)
- C-SITE Co., Ltd. (109670.KQ)
- ESG Inc. (ESGH)
- Winpac Inc (097800.KQ)
- Johnson Chemical Pharmaceutical Works Co Ltd (4747.TWO)
- XCF Global, Inc. (SAFX)
- ImageneBio, Inc. (IMA)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.